81
46
Growth Score 81 in past quarter
-6 pts
Heat Score 46 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
466040
Myst Therapeutics is a privately held biotechnology company focused on advancing novel T-cell therapies for solid tumors.
About the Company
Myst Therapeutics is a privately held biotechnology company focused on the development and commercialization of novel broad-spectrum cancer immunotherapy products designed to harness the power of a patient’s own immune system to destroy cancer cells. Myst is pursuing the development of an adoptive cell therapy utilizing enriched T cells from tumors
and peripheral blood that target a broad spectrum of cancer mutations.
